Plain-English translation of NCT05483374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational registry—meaning researchers will collect and track medical information from patients diagnosed with rare head and neck cancers, including cancers of the nasal cavity, sinuses, nasopharynx, salivary glands, and middle ear. The goal is to gather real-world data from across European hospitals to help doctors understand these uncommon cancers better and improve how they are treated.
Rare cancers like these receive less research attention and funding than common cancers, and doctors across Europe have very different success rates treating them. By collecting data from many patients and hospitals in one central registry, researchers hope to identify patterns, improve diagnosis, and develop better treatment strategies for these uncommon conditions.
You likely qualify if…
You likely don't qualify if…
Your participation would involve sharing your medical records and clinical information with the registry—information about your diagnosis, treatment, and how you're doing over time. You would not be receiving any new medication or undergoing any experimental procedures. Instead, doctors at your hospital would enter your existing medical data into a secure database to help researchers across Europe learn from your case and others like it.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Czechia
Germany
Italy